Last Updated: September 28, 2026

Prinston Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PRINSTON INC

PRINSTON INC has ninety-three approved drugs.

There are three tentative approvals on PRINSTON INC drugs.

Summary for Prinston Inc

US Patents:	0
Tradenames:	82
Ingredients:	81
NDAs:	93

Drugs and US Patents for Prinston Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Prinston Inc	LEVETIRACETAM	levetiracetam	TABLET;ORAL	078106-001	Feb 10, 2009	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET;ORAL	212697-001	Jul 23, 2020	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	078110-001	May 5, 2008	AB	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
Prinston Inc	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	205363-002	Dec 4, 2017	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	ESCITALOPRAM OXALATE	escitalopram oxalate	TABLET;ORAL	078032-002	Aug 28, 2015	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	LISDEXAMFETAMINE DIMESYLATE	lisdexamfetamine dimesylate	CAPSULE;ORAL	216266-005	Aug 25, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	CYCLOBENZAPRINE HYDROCHLORIDE	cyclobenzaprine hydrochloride	TABLET;ORAL	077797-001	Feb 28, 2007	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Prinston Inc

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.